Eurobio Scientific Société anonyme (EPA: ALERS)
France
· Delayed Price · Currency is EUR 25.80
0.00 (0.00%)
Nov 20, 2024, 5:35 PM CET
ALERS Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 6.64 | 4.84 | 24.94 | 60.54 | 73.48 | 3.15 | Upgrade
|
| Depreciation & Amortization | 7.73 | 8.85 | 9.63 | 7.87 | 7.01 | 6.37 | Upgrade
|
| Other Amortization | 6.45 | 4.3 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.03 | 0.06 | -1.77 | - | 0.3 | 0.11 | Upgrade
|
| Other Operating Activities | -0.01 | 0.39 | 1.43 | 1.17 | 2.4 | -2.21 | Upgrade
|
| Change in Accounts Receivable | -0.99 | 12.9 | 20.84 | 2.05 | -31.64 | -8.18 | Upgrade
|
| Change in Inventory | -3.05 | 2.04 | 0.24 | -3.3 | -3.4 | 0.45 | Upgrade
|
| Change in Unearned Revenue | -0.27 | -0.24 | 0.28 | -0.03 | -0.06 | -0.01 | Upgrade
|
| Change in Other Net Operating Assets | 6.61 | -6.35 | -12.52 | -2.39 | 6.84 | 5.31 | Upgrade
|
| Operating Cash Flow | 23.07 | 26.77 | 43.07 | 65.92 | 54.93 | 4.99 | Upgrade
|
| Operating Cash Flow Growth | -20.49% | -37.86% | -34.65% | 20.00% | 1000.82% | - | Upgrade
|
| Capital Expenditures | -3.12 | -4.05 | -2.83 | -1.85 | -2.3 | -1.59 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.54 | 1.9 | 2.52 | 0.1 | - | - | Upgrade
|
| Cash Acquisitions | 11.95 | -4.5 | -132.16 | - | -2.24 | -2.24 | Upgrade
|
| Investment in Securities | 5.02 | 6.34 | -9.28 | -3.72 | 0.55 | -0.55 | Upgrade
|
| Other Investing Activities | -0 | - | - | 0 | - | -0 | Upgrade
|
| Investing Cash Flow | 15.39 | -0.32 | -141.76 | -5.47 | -3.99 | -4.39 | Upgrade
|
| Long-Term Debt Issued | - | - | 105 | - | 20.7 | 4.65 | Upgrade
|
| Long-Term Debt Repaid | - | -18.2 | -9.25 | -15.96 | -11 | -10.23 | Upgrade
|
| Net Debt Issued (Repaid) | -17.53 | -18.2 | 95.75 | -15.96 | 9.7 | -5.58 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 3 | Upgrade
|
| Repurchase of Common Stock | -2.9 | -2.79 | -12.24 | -6.91 | - | - | Upgrade
|
| Other Financing Activities | -2.3 | -2.51 | -1.21 | -0.88 | -2.65 | -1.43 | Upgrade
|
| Financing Cash Flow | -22.73 | -23.5 | 82.31 | -23.76 | 7.05 | -4.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.1 | 0.15 | -0.08 | 0.14 | -0.06 | 0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | 0 | Upgrade
|
| Net Cash Flow | 15.84 | 3.09 | -16.45 | 36.83 | 57.94 | -3.39 | Upgrade
|
| Free Cash Flow | 19.96 | 22.71 | 40.24 | 64.07 | 52.63 | 3.4 | Upgrade
|
| Free Cash Flow Growth | -17.52% | -43.55% | -37.19% | 21.73% | 1448.97% | - | Upgrade
|
| Free Cash Flow Margin | 13.79% | 17.39% | 26.32% | 34.57% | 27.82% | 5.71% | Upgrade
|
| Free Cash Flow Per Share | 1.79 | 2.02 | 3.54 | 5.89 | 4.68 | 0.30 | Upgrade
|
| Cash Interest Paid | 2.3 | 2.47 | 1.23 | 0.46 | 0.62 | 0.91 | Upgrade
|
| Levered Free Cash Flow | 32.65 | 16.39 | 44.88 | 46.34 | 27.37 | 0.74 | Upgrade
|
| Unlevered Free Cash Flow | 35.31 | 19.11 | 45.67 | 46.6 | 27.74 | 1.17 | Upgrade
|
| Change in Net Working Capital | -16.19 | -3.68 | -19.58 | 3.24 | 27.73 | 3.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.